Cyberonics (CYBX) Jumps on Lazard Upgrade

Shares of Cyberonics (Nasdaq: CYBX) are surging today on the back of an upgrade over at Lazard Capital Markets. Cyberonics most recently traded at $16.43, up $2.06, or 14% from yesterday's close.

Lazard raised its investment rating on Cyberonics from Hold to Buy.

Cyberonics, Inc., a neuromodulation company, engages in the design, development, manufacture, and marketing of implantable medical devices that provide vagus nerve stimulation (VNS) therapy for the treatment of epilepsy and treatment-resistant depression.

You May Also Be Interested In

• New Street Research Upgrades Micron Technology (MU) to Buy
• Freedom Broker Upgrades Lifeway Foods (LWAY) to Buy
• Northland Upgrades Hyliion Holdings (HYLN) to Outperform 'on Improved Visibility to KARNO Commercialization'